Integrated pregnancy and perinatal management of complex fetal congenital heart disease: a preliminary retrospective

Xie Junshu1, Yin Fufen1, Yin Xiuju1

  • 1Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, 100044, China.

Insights

Integrated management of complex congenital heart disease (CHD) in fetuses resulted in favorable outcomes. Delivery timing and mode should be individualized, with prostaglandin use improving neonatal oxygen saturation and surgical interventions yielding high success rates.

Area of Science:

  • Perinatology
  • Pediatric Cardiology
  • Fetal Medicine

Background:

  • Congenital heart disease (CHD) is the leading cause of neonatal mortality globally.
  • Optimal management strategies for fetuses with complex CHD remain uncertain for obstetricians in China.

Purpose of the Study:

  • To investigate integrated pregnancy and perinatal management for fetuses diagnosed with complex CHD via prenatal ultrasound in China.

Main Methods:

  • Retrospective analysis of 123 fetuses with complex CHD diagnosed by prenatal ultrasound (2016-2023).
  • Evaluation of delivery timing, mode, genetic testing, postnatal interventions, and surgical outcomes.

Main Results:

  • Most common diagnosis was complete transposition of the great arteries (D-TGA) (56.1%).
  • Cesarean delivery rate was 62.6%; mean gestational age at delivery was 37.9 weeks.
  • Prostaglandin improved oxygen saturation (72.8% to 80.5%); 98.2% of 114 neonates had favorable surgical outcomes.

Conclusions:

  • Avoid preterm birth for fetuses with complex CHD; delivery mode should be based on obstetric factors.
  • Consider delivery at or beyond 39 weeks if maternal and fetal status are stable.
  • Prostaglandin and coordinated multidisciplinary care are crucial for favorable outcomes in complex fetal CHD.
Abstract